Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picovax Immunity Persistence in 4-year-old Children
NCT04448132Phase 4Completed
- Sponsor
- AJ Vaccines
- Start
- Nov 2020
- Primary completion
- May 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Picovax in poliomyelitis, sponsored by AJ Vaccines. Started Nov 2020; status: completed.
02
Drugs
Picovax
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT04448132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448132.